Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal deathGERBER, Stefan; VARDHANA, Santosh; MEAGHER-VILLEMURE, Kathleen et al.American journal of obstetrics and gynecology. 2005, Vol 193, Num 4, pp 1472-1477, issn 0002-9378, 6 p.Article

The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin α-amanitinGUNDALA, Sri; WELLS, Lisa D; MILLIANO, Michael T et al.Archives of toxicology. 2004, Vol 78, Num 2, pp 68-73, issn 0340-5761, 6 p.Article

Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid heamorrhageGUEORGUIEVA, Ivelina; CLARK, Simon R; MCMAHON, Catherine J et al.British journal of clinical pharmacology. 2008, Vol 65, Num 3, pp 317-325, issn 0306-5251, 9 p.Article

Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancerHUNG TRINH VIET; WAGSÄTER, Dick; HUGANDER, Anders et al.Oncology reports. 2005, Vol 14, Num 4, pp 915-918, issn 1021-335X, 4 p.Article

A disproportionate increase in IL-1β over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birthGENC, Mehmet R; WITKIN, Steven S; DELANEY, Mary L et al.American journal of obstetrics and gynecology. 2004, Vol 190, Num 5, pp 1191-1197, issn 0002-9378, 7 p.Article

Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteersBOROZDENKOVA, Svetlana; MANT, Timothy G. K; ALLEN, Elizabeth et al.International immunopharmacology (Print). 2011, Vol 11, Num 11, pp 1837-1843, issn 1567-5769, 7 p.Article

Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1β levels, and history of spontaneous abortionPERNI, Sriram C; VARDHANA, Santosh; TUTTLE, Sara L et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 4, pp 1318-1323, issn 0002-9378, 6 p.Conference Paper

Interleukin 1 receptor antagonist and tumor necrosis factor-α gene polymorphism in patients with end-stage renal failureSHU, Kuo-Hsiung; CHENG, Chi-Hung; WU, Ming-Ju et al.Renal failure. 2005, Vol 27, Num 1, pp 53-57, issn 0886-022X, 5 p.Article

Decreased levels of peritoneal interleukin-1 receptor antagonist in patients with endometriosis and disease-related dysmenorrheaXINMEI ZHANG; JIE WEN; LIN DENG et al.Fertility and sterility. 2007, Vol 88, Num 3, pp 594-599, issn 0015-0282, 6 p.Article

Alterations in peripheral blood lymphocyte cytokine expression in obesityO'ROURKE, R. W; KAY, T; LYLE, E. A et al.Clinical and experimental immunology (Print). 2006, Vol 146, Num 1, pp 39-46, issn 0009-9104, 8 p.Article

Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammationPALMER, Gaby; TALABOT-AYER, Dominique; KAYA, Gürkan et al.Journal of investigative dermatology. 2007, Vol 127, Num 8, pp 1938-1946, issn 0022-202X, 9 p.Article

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 DiabetesLARSEN, Claus M; FAULENBACH, Mirjam; VAAG, Allan et al.Diabetes care. 2009, Vol 32, Num 9, pp 1663-1668, issn 0149-5992, 6 p.Article

Interleukin-1-receptor antagonist in type 2 diabetes mellitusLARSEN, Claus M; FAULENBACH, Mirjam; VAAG, Allan et al.The New England journal of medicine. 2007, Vol 356, Num 15, pp 1517-1526, issn 0028-4793, 10 p.Article

Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individualsCULLUP, H; MIDDLETON, P. G; DUGGAN, G et al.Clinical and experimental immunology (Print). 2004, Vol 137, Num 2, pp 351-358, issn 0009-9104, 8 p.Article

Étude des polymorphismes des gènes de l'interleukine-1 et de l'antagoniste du récepteur de l'interleukine-1 chez des patients atteints de polyarthrite rhumatoïde = Interleukin-1 and the interleukin-1 receptor antagonist gene polymorphisms study in patients with rheumatoid arthritisALLAM, I; DJIDJIK, R; LADJOUZE-REZIG, A et al.Pathologie et biologie. 2013, Vol 61, Num 6, pp 264-268, issn 0369-8114, 5 p.Article

Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in miceWU, Zhen-Qian; HAN, Xiao-Dong; WANG, Zhi-Gang et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 1, pp 87-96, issn 0344-5704, 10 p.Article

Umbilical cord levels of interleukin-1 receptor antagonist and neonatal outcomeELSMEN, Emma; LEY, David; CILIO, Corrado M et al.Biology of the neonate. 2006, Vol 89, Num 4, pp 220-226, issn 0006-3126, 7 p.Article

Chronic inflammation as predictor of 1-year hospitalization and mortality in elderly populationDE GONZALO-CALVO, David; DE LUXAN-DELGADO, Beatriz; MARTINEZ-CAMBLOR, Pablo et al.European journal of clinical investigation. 2012, Vol 42, Num 10, pp 1037-1046, issn 0014-2972, 10 p.Article

Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1β and interleukin-1 receptor antagonist and pregnancy outcomeWITKIN, Steven S; VARDHANA, Santosh; YIH, Melissa et al.American journal of obstetrics and gynecology. 2003, Vol 189, Num 5, pp 1413-1417, issn 0002-9378, 5 p.Article

Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinomaKONISHI, Naomi; MIKI, Chikao; YOSHIDA, Toshimichi et al.Oncology. 2005, Vol 68, Num 2-3, pp 138-145, issn 0030-2414, 8 p.Article

Inflammation and Fatigue Dimensions in Advanced Cancer Patients and Cancer Survivors: An Explorative StudyDE RAAF, Pleun J; SLEIJFER, Stefan; LAMERS, Cor H. J et al.Cancer. 2012, Vol 118, Num 23, pp 6005-6011, issn 0008-543X, 7 p.Article

Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 DiabetesMAEDLER, Kathrin; DHARMADHIKARI, Gitanjali; SCHUMANN, Desiree M et al.Handbook of experimental pharmacology. 2011, Vol 203, pp 257-278, issn 0171-2004, 22 p.Article

Interleukin-1 gene cluster polymorphisms predict risk of ESRDWETMORE, James B; HUNG, Adriana M; LOVETT, David H et al.Kidney international. 2005, Vol 68, Num 1, pp 278-284, issn 0085-2538, 7 p.Article

Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?CAPPER, E. R; MASKILL, J. K; GORDON, C et al.Clinical and experimental immunology (Print). 2004, Vol 138, Num 2, pp 348-356, issn 0009-9104, 9 p.Article

Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome : a population-based studySALTEVO, J; VANHALA, M; KAUTIAINEN, H et al.Diabetic medicine. 2008, Vol 25, Num 6, pp 747-750, issn 0742-3071, 4 p.Article